A Phase 3 Active-Controlled Study of Maribavir (MBV) for the Treatment (Tx) of Transplant Recipients with Refractory/Resistant (RR) Cytomegalovirus (CMV): Study Design

被引：0
|
作者：
Sandberg, Aimee [1 ]
Alain, Sophie [2 ]
Avery, Robin [3 ]
Blumberg, Emily [4 ]
Kamar, Nassim [5 ]
Kotton, Camille [6 ]
Silveira, Femanda [7 ]
Wu, Jingyang [1 ]
机构：
[1] Shire, Lexington, MA USA
[2] Univ Limoges, CHU Limoges, Limoges, France
[3] Johns Hopkins Univ, Baltimore, MD USA
[4] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA
[5] CHU Rangueil, Toulouse, France
[6] Harvard Med Sch, Massachusetts Gen Hosp, Boston, MA 02115 USA
[7] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA
来源：
BIOLOGY OF BLOOD AND MARROW TRANSPLANTATION | 2020年 / 26卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
573
引用
收藏
页码：S370 / S371
页数：2
相关论文
共 50 条
  • [1] Oral maribavir for treatment of refractory or resistant cytomegalovirus infections in transplant recipients
    Avery, R. K.
    Marty, F. M.
    Strasfeld, L.
    Lee, I.
    Arrieta, A.
    Chou, S.
    Tatarowicz, W.
    Villano, S.
    TRANSPLANT INFECTIOUS DISEASE, 2010, 12 (06) : 489 - 496
  • [2] Maribavir for Treatment of Cytomegalovirus Infections Resistant or Refractory to Ganciclovir or Foscarnet in Solid Organ Transplant Recipients: A Phase 2 Study
    Pereira, M.
    Silveira, F.
    Papanicolaou, G.
    Langston, A.
    Avery, R.
    Wijatyk, A.
    Wu, J.
    Boeckh, M.
    Marty, F.
    Villano, S.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 405 - 405
  • [3] EXPERIENCE WITH THE USE OF MARIBAVIR IN HEMATOPOIETIC STEM CELL TRANSPLANT RECIPIENTS WITH REFRACTORY OR RESISTANT CYTOMEGALOVIRUS (CMV)
    Fernandez Perez, Monica
    Ceballos Bolanos, Candela
    Oiartzabal Ormategui, Itziar
    Arratibel Zalacain, Nerea
    Millacoy Austenrritt, Pamela
    Aranguren Ostolaza, Marina
    Viguria Alegria, Maria Cruz
    Panizo Santos, Carlos Manuel
    BONE MARROW TRANSPLANTATION, 2024, 59 : 475 - 476
  • [4] Phase 3 Study of Maribavir (MBV) vs. Investigator-Assigned Therapy (IAT) for Refractory/Resistant (R/R) Cytomegalovirus (CMV) Infection Post-Transplant: Analysis of Kidney Recipients and Renal Safety
    Shihab, Fuad S.
    Avery, Robin K.
    Blumberg, Emily
    Haririan, Abdolreza
    Wu, Jingyang
    Sundberg, Aimee K.
    JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2021, 32 (10): : 17 - 17
  • [5] PHASE 3 OPEN-LABEL STUDY OF MARIBAVIR FOR REFRACTORY/RESISTANT CYTOMEGALOVIRUS INFECTION IN TRANSPLANT RECIPIENTS: SUBGROUP ANALYSES BY ORGAN TYPE
    Kamar, Nassim
    Avery, Robin K.
    Blumberg, Emily A.
    Florescu, Diana
    Kumar, Deepali
    Wu, Jingyang
    Sundberg, Aimee
    TRANSPLANT INTERNATIONAL, 2021, 34 : 46 - 46
  • [6] Maribavir (MBV) versus Investigator-Assigned Therapy (IAT) for Refractory Cytomegalovirus (CMV) Infection (with or without Resistance) in Solid Organ Transplant (SOT) Recipients: Subgroup Safety Analysis of a Phase 3 Study.
    La Hoz, R. M.
    Florescu, D.
    Kumar, D.
    Saliba, F.
    Gu, J.
    Sundberg, A.
    AMERICAN JOURNAL OF TRANSPLANTATION, 2022, 22 : 353 - 353
  • [7] Efficacy and Safety of Maribavir as a Rescue Treatment for Investigator Assigned Therapy in Transplant Recipients With Refractory or Resistant Cytomegalovirus Infections in the SOLSTICE Study: Phase 3 Trial Results
    Pereira, Marcus
    Cervera, Carlos
    Kotton, Camille
    Sasadeusz, Joe
    Wu, Jackie
    Fournier, Martha
    Shardlow, Richard
    BRITISH JOURNAL OF HAEMATOLOGY, 2022, 197 : 7 - 8
  • [8] Phase 3 Randomized, double-blind Study of Maribavir Compared with Valganciclovir for Treatment of Cytomegalovirus (CMV) Infection in Hematopoietic stem-cell Transplant (HSCT) Recipients (Study Design)
    Maertens, Johan
    Alain, Sophie
    Avery, Robin
    Murray, Rose Ann
    Wu, Jingyang
    Ljungman, Per
    BONE MARROW TRANSPLANTATION, 2020, 55 (SUPPL 1) : 500 - 500
  • [9] Drug Resistance Assessed in a Phase 3 Clinical Trial of Maribavir Therapy for Refractory or Resistant Cytomegalovirus Infection in Transplant Recipients
    Chou, Sunwen
    Alain, Sophie
    Cervera, Carlos
    Chemaly, Roy F.
    Kotton, Camille N.
    Lundgren, Jens
    Papanicolaou, Genovefa A.
    Pereira, Marcus R.
    Wu, Jingyang J.
    Murray, Rose Ann
    Buss, Neil E.
    Fournier, Martha
    JOURNAL OF INFECTIOUS DISEASES, 2024, 229 (02): : 413 - 421
  • [10] Evaluating Real-World Experience With Maribavir for Treatment of Refractory/Resistant Cytomegalovirus in Renal Transplant Recipients
    Beechar, Vivek B.
    Phadke, Varun K.
    Pouch, Stephanie M.
    Mehta, Aneesh K.
    Karadkhele, Geeta
    Larsen, Christian P.
    Woodworth, Michael H.
    CLINICAL TRANSPLANTATION, 2024, 38 (10)
12345